Mandeep R. Mehra
#40,097
Most Influential Person Now
American professor of medicine
Mandeep R. Mehra's AcademicInfluence.com Rankings
Mandeep R. Mehraphilosophy Degrees
Philosophy
#3783
World Rank
#6058
Historical Rank
#1168
USA Rank
Logic
#1403
World Rank
#2149
Historical Rank
#421
USA Rank
Download Badge
Philosophy
Why Is Mandeep R. Mehra Influential?
(Suggest an Edit or Addition)According to Wikipedia, Mandeep R. Mehra is The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine and a professor of medicine at Harvard Medical School. He is the medical director of the Brigham Heart and Vascular Center in Boston, Massachusetts, and specializes in advanced heart failure, mechanical circulatory support and cardiac transplantation.
Mandeep R. Mehra's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Endothelial cell infection and endotheliitis in COVID-19 (2020) (4714)
- Extrapulmonary manifestations of COVID-19 (2020) (1998)
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal (2020) (1368)
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 (2020) (1001)
- The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. (2016) (949)
- Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. (2006) (892)
- International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. (2010) (742)
- Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. (2006) (723)
- RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (2020) (702)
- Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (2020) (604)
- A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report (2019) (582)
- A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure (2017) (564)
- Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure (2018) (516)
- Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. (2013) (488)
- Obesity and suppressed B-type natriuretic peptide levels in heart failure. (2004) (485)
- Body composition and prognosis in chronic systolic heart failure: the obesity paradox. (2002) (479)
- Omega-3 polyunsaturated fatty acids and cardiovascular diseases. (2009) (477)
- Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621. (2020) (404)
- The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. (2013) (383)
- Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. (2005) (383)
- Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) (2010) (381)
- BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. (2004) (376)
- Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. (2010) (370)
- Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association (2018) (349)
- HFSA 2006 comprehensive heart failure practice guideline (2006) (329)
- Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease (2018) (238)
- Reduction in C-reactive protein through cardiac rehabilitation and exercise training. (2004) (237)
- Amyloidosis and the heart: a comprehensive review. (2006) (236)
- Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide (2020) (232)
- Patient Selection for Cardiac Resynchronization Therapy: From the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Heart Rhythm Society (2005) (229)
- Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. (2005) (227)
- Heart and Lung Transplants from HCV‐Infected Donors to Uninfected Recipients (2019) (216)
- Pharmaco-Immunomodulatory Therapy in COVID-19 (2020) (199)
- The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). (2011) (198)
- Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF (2008) (198)
- Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. (2006) (193)
- Chronic heart failure: contemporary diagnosis and management. (2010) (189)
- Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. (1995) (182)
- The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. (2000) (177)
- The vexing problem of thrombosis in long-term mechanical circulatory support. (2014) (177)
- An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. (2019) (166)
- Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. (2006) (165)
- Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure (2017) (164)
- Understanding the basics of cardiopulmonary exercise testing. (2006) (154)
- Report from a consensus conference on the sensitized patient awaiting heart transplantation. (2009) (149)
- Cardiopulmonary Exercise Testing: How Do We Differentiate the Cause of Dyspnea? (2004) (148)
- Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. (2009) (142)
- Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes: Lessons Learned and Directions Forward (2010) (141)
- Obesity and heart failure prognosis: paradox or reverse epidemiology? (2005) (137)
- Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. (2005) (133)
- COVID-19 Illness and Heart Failure (2020) (131)
- Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. (2012) (128)
- Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. (2007) (128)
- Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. (2007) (118)
- Impact of exercise training and depression on survival in heart failure due to coronary heart disease. (2011) (118)
- Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. (2008) (118)
- Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. (2006) (114)
- HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (114)
- Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. (2016) (112)
- Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. (2002) (111)
- Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. (2013) (110)
- Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. (2016) (110)
- An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy. (1995) (108)
- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial (2021) (108)
- Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. (2004) (107)
- Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains (2013) (107)
- Molecular testing in the management of cardiac transplant recipients: initial clinical experience. (2006) (106)
- Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. (2009) (106)
- Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study. (2018) (106)
- Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States. (2020) (103)
- HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (101)
- Peak exercise oxygen pulse and prognosis in chronic heart failure. (2004) (101)
- Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. (1995) (100)
- A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. (2005) (100)
- Cardiac allograft vasculopathy: current concepts. (1993) (98)
- Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. (2015) (93)
- Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. (1994) (93)
- The burden of haemocompatibility with left ventricular assist systems: a complex weave. (2019) (90)
- Cardiac resynchronization therapy: caveat medicus! (2004) (90)
- Heart failure therapy at a crossroad: are there limits to the neurohormonal model? (2003) (89)
- Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF (2012) (88)
- Renin-angiotensin system: genes to bedside. (1997) (87)
- Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump (2019) (86)
- Associations Between Outpatient Heart Failure Process-of-Care Measures and Mortality (2011) (86)
- The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. (1996) (82)
- Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. (2004) (82)
- Left Ventricular Assist Devices for Lifelong Support. (2017) (81)
- The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. (1997) (81)
- Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. (2006) (80)
- Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine (1997) (80)
- Comparison of Medical Therapy Dosing in Outpatients Cared for in Cardiology Practices With Heart Failure and Reduced Ejection Fraction With and Without Device Therapy: Report From IMPROVE HF (2010) (76)
- COVID-19: Yet another coronavirus challenge in transplantation (2020) (75)
- The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. (2004) (74)
- Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent (2020) (73)
- Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. (2012) (69)
- Social Worker–Aided Palliative Care Intervention in High-risk Patients With Heart Failure (SWAP-HF): A Pilot Randomized Clinical Trial (2018) (68)
- Right heart failure: toward a common language. (2014) (68)
- Clinical myocardial recovery during long-term mechanical support in advanced heart failure: Insights into moving the field forward. (2016) (68)
- Allosensitization in heart transplantation: implications and management strategies (2003) (67)
- Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. (2019) (67)
- Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. (1997) (66)
- Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. (1999) (66)
- HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. (2014) (66)
- Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy (2018) (65)
- Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart Transplantation: More Than a Hemodynamic Marker (2006) (64)
- Metaanalysis of statins and survival in de novo cardiac transplantation. (2004) (64)
- A new "twist" on right heart failure with left ventricular assist systems. (2017) (64)
- Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory. (2009) (63)
- A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial (2019) (62)
- Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure (2013) (61)
- Current and future challenges in therapy for antibody-mediated rejection. (2011) (60)
- Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy (2021) (59)
- Ethnic Disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression (2002) (59)
- Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. (1999) (58)
- The Drug-Intoxication Epidemic and Solid-Organ Transplantation. (2018) (58)
- Rural-Urban Differences in Cardiovascular Mortality in the US, 1999-2017. (2020) (57)
- Obesity paradox, cachexia, frailty, and heart failure. (2014) (57)
- Anything but a biopsy: noninvasive monitoring for cardiac allograft rejection (2002) (57)
- The Economic Implications of Noninvasive Molecular Testing for Cardiac Allograft Rejection (2005) (56)
- Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. (2002) (55)
- Electron microscopy of SARS-CoV-2: a challenging task – Authors' reply (2020) (55)
- Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. (2009) (54)
- Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates (2019) (54)
- Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. (2009) (53)
- Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (53)
- Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. (2009) (53)
- Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. (2002) (53)
- Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial. (2019) (52)
- Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes. (1997) (52)
- Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. (2009) (51)
- Coronary stenting in cardiac allograft vasculopathy. (1998) (51)
- Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. (2005) (50)
- Modulatory impact of cardiac rehabilitation on hyperhomocysteinemia in patients with coronary artery disease and "normal" lipid levels. (1998) (49)
- Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis. (2007) (48)
- Sexual activity and chronic heart failure. (2007) (48)
- Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation (2017) (48)
- Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial. (2019) (47)
- Cardiac Troponin Levels in Heart Failure (2004) (47)
- Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study. (1994) (46)
- Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure (2018) (46)
- Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. (2004) (46)
- Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%): a comparison of bypass grafting and percutaneous intervention. (2002) (46)
- Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). (2010) (45)
- Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants (2021) (45)
- HFSA 2010 Guideline Executive Summary Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline (2006) (44)
- Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. (2010) (44)
- Adults with congenital heart disease and heart transplantation: optimizing outcomes. (2014) (44)
- Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry. (2005) (44)
- Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure. (2009) (44)
- Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. (2020) (43)
- Ancient Egyptian medicine and the concept of heart failure. (2006) (43)
- A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. (2018) (42)
- The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation. (1997) (42)
- High-density lipoprotein cholesterol levels and prognosis in advanced heart failure. (2009) (42)
- Postmarketing Adverse Events Related to the CardioMEMS HF System (2017) (41)
- Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation. (1998) (40)
- Clinical implications and longitudinal alteration of peripheral blood transcriptional signals indicative of future cardiac allograft rejection. (2008) (40)
- Effects of aerobic exercise training on indices of ventricular repolarization in patients with chronic heart failure. (1999) (40)
- The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. (2006) (40)
- Tobacco Smoke Exposure in Either the Donor or Recipient Before Transplantation Accelerates Cardiac Allograft Rejection, Vascular Inflammation, and Graft Loss (2009) (39)
- Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working Group. (2012) (39)
- Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF). (2019) (39)
- Right Heart Failure: Toward a Common Language (2013) (39)
- Clinical Effectiveness of Cardiac Resynchronization and Implantable Cardioverter-Defibrillator Therapy in Men and Women With Heart Failure: Findings From IMPROVE HF (2014) (38)
- Organ allocation around the world: insights from the ISHLT International Registry for Heart and Lung Transplantation. (2014) (38)
- 398: Premature termination of a prospective, open label, randomized, multicenter study of sirolimus to replace calcineurin inhibitors (CNI) in a standard care regimen of CNI, MMF and corticosteroids early after heart transplantation (2007) (37)
- Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. (2020) (37)
- Induction therapy in heart transplantation: is there a role? (2007) (37)
- Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men. (1997) (36)
- Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. (2020) (36)
- Recrudescent Tobacco Exposure Following Heart Transplantation: Clinical Profiles and Relationship with Athero‐Thrombosis Risk Markers (2005) (36)
- Ventilation/carbon dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure. (1996) (35)
- The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. (1995) (35)
- Electronic health records and quality of care for heart failure. (2010) (35)
- Gallstone Disease in Heart Transplant Recipients (2003) (34)
- The independent prognostic impact of decreased high density lipoprotein levels in severe heart failure (2001) (34)
- Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. (2019) (34)
- ISHLT International Registry for Heart and Lung Transplantation--into the fourth decade, from strength to strength. (2013) (34)
- Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model (2012) (33)
- Implications of obesity across the heart failure continuum (2020) (33)
- Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registry. (2014) (33)
- Reasons for Guideline Nonadherence at Heart Failure Discharge (2018) (32)
- Transcriptional signals of T-cell and corticosteroid-sensitive genes are associated with future acute cellular rejection in cardiac allografts. (2007) (32)
- Strategy for surgical correction and mitigation of outflow graft twist with a centrifugal-flow left ventricular assist system. (2018) (32)
- Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis (2019) (32)
- Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened. (2005) (31)
- Early aspirin use and the development of cardiac allograft vasculopathy. (2017) (31)
- Prevention of atherosclerosis. (1995) (31)
- C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link? (2003) (31)
- Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy. (1997) (31)
- Cyclosporine-induced hypertension in cardiac transplantation. (1997) (31)
- Implications for the vascular surgeon with prolonged (3 to 89 days) intraaortic balloon pump counterpulsation. (1997) (30)
- Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices (2009) (30)
- Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure. (2011) (29)
- Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. (2009) (29)
- Anticoagulation in heart failure: current status and future direction (2013) (29)
- Obesity, weight reduction and survival in heart failure. (2002) (28)
- It is time to stop ignoring malignancy in heart transplantation: a call to arms. (2005) (28)
- Gene expression profiling and cardiac allograft rejection monitoring: is IMAGE just a mirage? (2010) (28)
- Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period (2011) (27)
- The emergence of genomic and proteomic biomarkers in heart transplantation. (2005) (27)
- Association of Post-Diagnosis Cardiorespiratory Fitness with Cause-Specific Mortality in Cancer. (2020) (27)
- Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF. (2010) (27)
- Optimizing outcomes in the patient with acute decompensated heart failure. (2006) (27)
- Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. (2022) (27)
- Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device. (2014) (27)
- Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device. (2020) (26)
- Study of arterial and autonomic effects of cyclosporine in humans. (2000) (26)
- Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure. (1998) (26)
- Surrogate Markers for Late Cardiac Allograft Survival (2004) (26)
- Lipid-lowering therapy and long-term survival in heart transplantation. (1997) (26)
- Advancing from a "hemodynamic model" to a "mechanistic disease-modifying model" of cardiogenic shock. (2018) (25)
- B-Type Natriuretic Peptide in Heart Transplantation: An Important Marker of Allograft Performance (2003) (25)
- Mechanical circulatory support devices in advanced heart failure: 2020 and beyond. (2020) (25)
- Long-term immunosuppression and malignancy in thoracic transplantation: where is the balance? (2014) (25)
- Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation (2003) (25)
- Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. (2018) (25)
- Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection. (2011) (25)
- Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. (2004) (25)
- Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study. (2020) (25)
- Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation. (2016) (25)
- Dilemma of organ donation in transplantation and the COVID-19 pandemic (2020) (25)
- Evolocumab in Patients with Cardiovascular Disease. (2017) (24)
- Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. (2020) (24)
- Immune reconstitution inflammatory syndrome and human immunodeficiency virus-associated myocarditis. (2008) (24)
- Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement (2020) (24)
- Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial (2021) (24)
- Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). (2010) (24)
- COVID-19 vaccination immune paresis in heart and lung transplantation (2021) (23)
- Relationship among epicardial coronary disease, tissue myocardial perfusion, and survival in heart transplantation. (2005) (23)
- Desperate diseases, desperate measures: tackling malignant hypertension in the 1950s. (2001) (23)
- TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit? (2003) (22)
- Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control. (1996) (22)
- Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study). (2011) (22)
- Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside. (1995) (22)
- Lack of Association Between Electronic Health Record Systems and Improvement in Use of Evidence‐Based Heart Failure Therapies in Outpatient Cardiology Practices (2012) (22)
- Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). (2010) (22)
- Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. (2008) (22)
- Emergence of electronic home monitoring in chronic heart failure: rationale, feasibility, and early results with the HomMed Sentry-Observer system. (2000) (22)
- Crossing the vasculopathy bridge from morphology to therapy: a single center experience. (2000) (21)
- Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events (2013) (21)
- Surgery for severe mitral regurgitation and left ventricular failure: what do we really know? (2008) (21)
- Rationale and process: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. (2006) (21)
- Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis. (2020) (21)
- Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. (2001) (20)
- Patient Selection for Cardiac Resynchronization Therapy (2005) (20)
- Hypersensitivity eosinophilia in advanced heart failure: a clinical marker for impending decompensation and cytokine deployment (1999) (20)
- Bloodletting as a cure for dropsy: heart failure down the ages. (2005) (20)
- Management of cardiac allograft vasculopathy by transmyocardial laser revascularization. (1997) (20)
- Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems. (2018) (20)
- Early recognition and treatment of hypertensive heart disease (2005) (20)
- AN UPDATE ON CLINICAL OUTCOMES IN HEART AND LUNG TRANSPLANTATION (2004) (20)
- Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure. (2005) (20)
- Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox. (2003) (20)
- The dawn of the ISHLT Mechanical Assisted Circulatory Support (IMACS) Registry: fulfilling our mission. (2012) (19)
- Predicting prognosis in advanced heart failure. Use of exercise indices. (1996) (19)
- Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure. (2010) (19)
- New developments in the diagnosis and management of cardiac allograft vasculopathy. (1995) (19)
- Mechanical circulatory support and heart transplantation in the Asia Pacific region. (2017) (18)
- Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF. (2020) (18)
- Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study. (2021) (18)
- The influence of corticosteroids on the alloimmune molecular signature for cardiac allograft rejection (2005) (18)
- Gut dysbiosis and heart failure: navigating the universe within (2020) (18)
- Bedside b-type natriuretic peptide and acute non-cellular cardiac allograft rejection. (2002) (18)
- B-type natriuretic peptide in heart failure: diagnostic, prognostic, and therapeutic use. (2005) (17)
- The Mona Lisa Decrypted: Allure of an Imperfect Reality. (2018) (17)
- Incidental Coronary Artery Calcification in Cancer Imaging (2019) (17)
- Bridging patients to cardiac transplantation. (2000) (17)
- A history of devices as an alternative to heart transplantation. (2014) (17)
- Methodological Challenges of Genomic Research—The Cargo Study (2006) (17)
- Lean body mass adjusted cardiopulmonary variables incrementally predict prognosis in chronic systolic heart failure (2002) (16)
- Site selection for heart failure clinical trials in the USA (2015) (16)
- Molecular testing and prediction of clinical outcome in heart transplantation: a prospective multicenter trial (2004) (15)
- Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy. (2001) (15)
- "Flexo-dyspnea": A novel clinical observation in the heart failure syndrome. (2013) (15)
- Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure. (2011) (15)
- All Patients With Heart Failure and Intraventricular Conduction Defect or Dyssynchrony Should Not Receive Cardiac Resynchronization Therapy (2006) (15)
- Improvement of heart failure after renal transplantation: the complex maze of cardio-renal interaction. (2005) (15)
- Factors Associated with Improvement in Guideline‐Based Use of ICDs in Eligible Heart Failure Patients (2012) (15)
- Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices (2018) (15)
- Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis (2020) (15)
- Exercise training in patients with a left ventricular assist device (Ex‐VAD): rationale and design of a multicentre, prospective, assessor‐blinded, randomized, controlled trial (2019) (15)
- Ischemic stroke and subsequent thrombosis within a HeartMate 3 left ventricular assist system: A cautionary tale. (2018) (15)
- Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure. (2016) (15)
- A proposed strategy for management of immunosuppression in heart transplant patients with COVID‐19 (2020) (14)
- Continuous flow left ventricular assist device related aortic root thrombosis complicated by left main coronary artery occlusion. (2014) (14)
- The growing burden of heart failure: the "syndemic" is reaching Latin America. (2004) (14)
- Fat, cachexia, and the right ventricle in heart failure: a web of complicity. (2013) (14)
- Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring (2020) (14)
- The scourge and enigmatic journey of cardiac allograft vasculopathy. (2017) (14)
- Pump thrombosis redux. (2015) (14)
- HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy. (2021) (14)
- The International Society for Heart and Lung Transplantation Registries in the Era of Big Data With Global Reach. (2015) (13)
- Advanced cancer is also a heart failure syndrome: a hypothesis (2020) (13)
- The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside (2006) (13)
- Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume. (2002) (13)
- Advances in heart and lung transplantation 2004: Report from the 24th International Society for Heart and Lung Transplantation Annual Meeting, San Francisco, April 21-24, 2004. (2004) (13)
- Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative. (2020) (13)
- Brain injury and ventricular dysfunction: insights into reversible heart failure. (2005) (12)
- COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure. (2006) (12)
- Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial (2020) (12)
- Reduction in hs-CRP in coronary patients with exercise training and diet (2001) (12)
- Cocaine use in organ donors and long-term outcome after heart transplantation: An International Society for Heart and Lung Transplantation registry analysis. (2020) (12)
- Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms. (2015) (12)
- Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. (2001) (12)
- Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy. (1997) (12)
- Further analysis of the intravascular ultrasound data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipients (2004) (12)
- A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. (2001) (12)
- Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States (2021) (11)
- Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy. (2020) (11)
- Gene-based bio-signature patterns and cardiac allograft rejection. (2010) (11)
- Clopidogrel and rhabdomyolysis after heart transplantation. (2003) (11)
- Myocardial edema in COVID-19 on cardiac MRI (2020) (11)
- Body Composition and Advanced Heart Failure Therapy: Weighing the Options and Outcomes. (2016) (11)
- Adenovirus-mediated in vivo gene transfer in a rabbit model of allograft vasculopathy. (1996) (11)
- Heart transplantation at 50 (2017) (11)
- Evolution in Mechanical Circulatory Support: Are We at the Precipice of a Disruptive Innovation? (2015) (11)
- Renin angiotensin aldosterone and adrenergic modulation in chronic heart failure: contemporary concepts. (2002) (11)
- Pulmonary hypertension: the great leveler. (2012) (11)
- Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. (2001) (10)
- Organ Donation and Drug Intoxication-Related Deaths in the United States. (2019) (10)
- Adverse effects of nicotine and immunosuppression on proximal tubular epithelial cell viability, tissue repair and oxidative stress gene expression. (2009) (10)
- Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses. (2000) (10)
- Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial (1999) (10)
- Emerging Trends in Financing of Adult Heart Transplantation in the United States. (2019) (10)
- Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support (2019) (10)
- Peak oxygen consumption and heart failure prognosis in women. (2007) (10)
- Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy (2021) (10)
- Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertension. (2008) (10)
- Guidelines for Listing Candidates for Heart Transplant: A 10-Year Update. (2017) (10)
- Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. (2021) (10)
- Prevention of atherosclerosis. The potential role of antioxidants. (1995) (10)
- Increasing complexity of thoracic transplantation and the rise of multiorgan transplantation around the world: Insights from the International Society for Heart and Lung Transplantation Registry. (2018) (10)
- Risk factors for death or heart transplantation in single-ventricle physiology (tricuspid atresia, pulmonary atresia, and heterotaxy): A systematic review and meta-analysis. (2019) (10)
- STAMINA-HFP (study of anemia in a heart failure population) registry: rationale, design, and patient characteristics (2003) (9)
- Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. (2022) (9)
- The progressive cardiorenal syndrome in heart failure: Mechanisms and therapeutic insights (2008) (9)
- PRospective Evaluation of Cardiac Decompensation in Patients with Heart Failure by Impedance Cardiography Test: The PREDICT Multicenter Trial (2004) (9)
- Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. (2004) (9)
- Treatment of heart failure according to William Stokes: the enchanted mercury. (2001) (9)
- Emergent use of mechanical circulatory support devices: ethical dilemmas (2014) (9)
- Isolated tricuspid stenosis and heart failure: a focus on carcinoid heart disease. (2003) (9)
- The dilemma of late-stage heart failure. Rationale for chronic parenteral inotropic support. (2001) (9)
- Heart Failure: A Global Pandemic and Not Just a Disease of the West. (2015) (9)
- Genomic biomarkers and heart transplantation. (2007) (8)
- ISHLT Transplant Registry: Youthful Investment-The Path to Progress. (2017) (8)
- Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF. (2012) (8)
- Challenges in long-term mechanical circulatory support and biological replacement of the failing heart. (2014) (8)
- Factors Associated with Improvement in Utilization of Cardiac Resynchronization Therapy in Eligible Heart Failure Patients: Findings from IMPROVE HF (2013) (8)
- New Data on the Clinical Impact of Exercise Training, Fish Oils, and Statins in Heart Failure (2009) (8)
- Radiocontrast-induced nephropathy. Prevention is better than cure. (1992) (8)
- Late-onset right heart failure after left ventricular assist device implant: quo vadis? (2017) (8)
- Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study). (2002) (8)
- Colles-Stokes contributions to the concept of heart failure. (1998) (8)
- Anticoagulation management strategies in heart transplantation. (2020) (8)
- Isolated hyperammonemic encephalopathy in heart transplantation. (2017) (8)
- The heart-gut microbiome axis in advanced heart failure. (2020) (8)
- Hippocrates and prognosis in heart failure: the challenge of static and dynamic measurements. (2003) (8)
- Refining pathological classification of acute rejection in cardiac allograft recipients: a multicenter study using peripheral blood gene expression profiling (2004) (7)
- Challenges, diligence, and a breakthrough in donation after circulatory death in heart transplantation. (2017) (7)
- Advanced cancer is also a heart failure syndrome: a hypothesis (2021) (7)
- Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF. (2009) (7)
- A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective. (2021) (7)
- Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes (2016) (7)
- Long-Term Survival After Heart Transplantation at Centers Stratified by Short-Term Performance. (2019) (7)
- The Challenge of Neurocognitive Dysfunction in Severe Heart Failure (2002) (7)
- Emergence of Laplace therapeutics: declaring an end to end-stage heart failure. (2002) (7)
- patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial). (2011) (7)
- Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable (2018) (7)
- Comparison of cardiac and peripheral arterial stiffening and ventriculovascular uncoupling in patients with uncomplicated hypertension versus patients with hypertension after heart transplantation. (2006) (6)
- Center Variability in Patient Outcomes following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. (2022) (6)
- The interaction of vascular stiffness and cardiovascular events in women: insights from The Heart and Estrogen/Progestin Replacement Study. (2005) (6)
- Cardiac Xenotransplantation: Rebirth Amidst An Uncertain Future. (2022) (6)
- Highlights of the 2007 Scientific Meeting of the Heart Failure Society of America: Washington, DC, September 16-19, 2007. (2008) (6)
- Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits. (2010) (6)
- A Randomized Controlled Trial of a Social Worker-Aided Palliative Care Intervention in High Risk Patients with Heart Failure (SWAP-HF) (2016) (6)
- Left Ventricular Reverse Remodeling in Heart Failure: Remission to Recovery (2021) (6)
- 191: The clinical role of gene expression testing in anticipating the future development of acute cardiac allograft rejection (2006) (6)
- Impact of Geographic Region on the COMMANDER-HF Trial. (2020) (6)
- The gut microbiome and transplantation: An amazon jungle. (2018) (6)
- Heart ambulatory treatment of worsening heart failure with intravenous loop diuretics: A four-year experience. (2019) (6)
- Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. (2002) (6)
- Mitral regurgitation in chronic heart failure: More questions than answers? (2004) (6)
- Ideal weight, body composition and lipid levels: An unresolved dilemma? Reply (2001) (6)
- Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design (2008) (6)
- Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis. (2015) (5)
- Multi-center intravascular ultrasound validation study among heart transplant recipients: outcomes after 5 years (2004) (5)
- Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction (2022) (5)
- Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” (2020) (5)
- Advanced heart failure: Trans‐Atlantic perspectives on the Heart Failure Association of the European Society of Cardiology position statement (2018) (5)
- B-type natriuretic peptide levels are closely associated with anemia in chronic heart failure independent of underlying renal dysfunction (2003) (5)
- The conundrum of sleep breathing disorders in heart failure. (2003) (5)
- Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device. (2022) (5)
- Does donor and recipient sex influence the development of cardiac allograft vasculopathy? (1995) (5)
- An ACE in the hole: Unraveling gastrointestinal bleeding in left ventricular assist systemsAn ACE In The Hole: Unraveling Gastrointestinal Bleeding in Left Ventricular Assist Systemsretain-->. (2017) (5)
- Is heart failure with preserved systolic function an overlooked enigma? (2002) (5)
- Is it constrictive pericarditis or restrictive cardiomyopathy? A systematic approach. (2004) (5)
- The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure. (2020) (5)
- Update on left ventricular assist devices as a bridge to recovery (2001) (5)
- Transplanting Thoracic Organs from Hepatitis C Positive Donors to Hepatitis C Uninfected Recipients (2018) (5)
- Amiodarone Lung Injury: Another Heart Failure Mimic? (2002) (5)
- B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF (2012) (5)
- Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of IMPROVE HF (2009) (5)
- Special Article - Palliative care considerations for cardiovascular clinicians in COVID-19 (2020) (5)
- Utility of heart biopsy in transplant patients. (2001) (4)
- Prediction of optimal outcomes in organ transplantation (2018) (4)
- Reappraisal of the safety and effectiveness of Impella pumps (2020) (4)
- Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE (2021) (4)
- Difficult cases in heart failure: the challenge of neurocognitive dysfunction in severe heart failure. (2002) (4)
- Changing climate in heart failure : Towards a new era (1998) (4)
- Cardiomyopathy and the dilemma of geometric mitral regurgitation (2009) (4)
- Correlation of laboratory haemoconcentration measures with filling pressures obtained via pulmonary arterial pressure sensors in ambulatory heart failure patients (2020) (4)
- Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease. (1999) (4)
- Kinetics of generic tacrolimus in heart transplantation: A cautionary note. (2021) (4)
- Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device (2021) (4)
- Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015 (2020) (4)
- Difficult cases in heart failure: Expanding the therapeutic armamentarium in decompensated heart failure: using intravenous fenoldopam. (2001) (4)
- Durable mechanical circulatory support across the Asia-Pacific region (2020) (4)
- Scientific progress in heart and lung failure, mechanical circulatory support, and transplantation: highlights from the Journal of Heart and Lung Transplantation. (2014) (4)
- Robert James Graves and the cardiovascular responses to postural changes in heart failure. (2000) (4)
- Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal. (2020) (4)
- Early Immunosuppression and Rapid Recovery of Cardiogenic Shock in Multisystem Inflammatory Syndrome From Convalescent COVID-19 (2021) (4)
- (80) - Antimicrobial Surgical Prophylaxis in MCS Implant Surgery and Surgical Site Infection, IMACS January 2013 to December 2015 (2017) (4)
- Comorbid conditions in heart failure: an unhappy marriage. (2014) (4)
- Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation (2021) (4)
- Heart failure in the course of a pandemic (2020) (4)
- Vulnerable Brain and Ventricular Assist Devices. (2016) (4)
- The Dilemma of Exertional Dyspnea and Diagnosis of Heart Failure: Convergent and Discriminant Validity. (2018) (3)
- Vibrio vulnificus sepsis in solid organ transplantation: a medical nemesis. (1995) (3)
- Highlights of the 2006 Scientific Sessions of the Heart Failure Society of America (2009) (3)
- Longitudinal monitoring of cardiac allograft recipients using peripheral blood gene expression profiling: A retrospective observational analysis of molecular testing in 19 case studies (2005) (3)
- Durable mechanical circulatory support in advanced heart failure: a critical care cardiology perspective. (2013) (3)
- Anticoagulation management strategies in heart transplantation. (2020) (3)
- Prothrombin Complex Concentrate for Non-Bleeding Urgent Warfarin Reversal in Ventricular Assist Device Patients Undergoing Heart Transplantation (2016) (3)
- Rhabdomyolysis with the combined use of danazol and rosuvastatin in left ventricular assist devices. (2020) (3)
- Sildenafil and assessment of pulmonary arterial reactivity in heart failure. (2003) (3)
- Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure (2017) (3)
- Balancing the tightrope of cardiac allograft rejection: equations or experience? (2012) (3)
- Case‐control study of heart rate abnormalities across the breast cancer survivorship continuum (2018) (3)
- Assisted Circulation in the Treatment of Heart Failure (2012) (3)
- Diastolic dysfunction: An important predictor of survival in patients with preserved systolic function (2003) (3)
- Heart transplantation candidacy (2020) (3)
- Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies. (2022) (3)
- The Heart Failure Society of America in 2020: a vision for the future. (2012) (3)
- Advancing Immunosuppression in Heart Transplantation: “One Step Forward, Two Steps Back (2013) (3)
- Heart Failure With Preserved Ejection Fraction: Separating the Wheat From the Chaff. (2020) (3)
- Difficult cases in heart failure. Novel diagnostic markers in heart failure: an emerging paradigm shift? (2001) (3)
- Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. (2022) (3)
- White coat hypertension and sleep apnea: is there a link? (2004) (3)
- Risk assessment in critically ill patients awaiting transplantation: a step forward. (2011) (3)
- Pulsed inotropic therapy: an evangelical haven or justified sanctuary. (1999) (3)
- Results of A Multicenter, Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects with Stable Chronic Heart Failure (The COMPARE Trial) (10/7/08) (2008) (3)
- Electronic home monitoring reduces medical resource utilization in chronic heart failure: a prospective investigation of the HomMed-sentry telemonitoring system (2004) (3)
- Cardiac Transplantation. The Columbia University Medical Center/New York‐Presbyterian Hospital Manual (2005) (3)
- Destination therapy in late-stage heart failure (2004) (3)
- Lower Hemoglobin Is Associated with Persistently Reduced Quality of Life in Unselected Patients with Heart Failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry (2004) (3)
- The Opioid Use Crisis and Organ Transplantation: A Comparison of the United States and Europe (2018) (3)
- Grip Strength Assessment and Early Outcomes in Hospitalized Acute Decompensated Heart Failure: A Prospective Study (2015) (3)
- Does HDL-cholesterol level predict clinical outcome in advanced heart failure? (2001) (3)
- New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial (2021) (3)
- DIAGNOSTIC ACCURACY OF ADVANCED IMAGING IN CARDIAC SARCOIDOSIS: AN IMAGING-HISTOLOGIC CORRELATION STUDY IN PATIENTS UNDERGOING CARDIAC TRANSPLANTATION (2019) (3)
- Difficult cases in heart failure: amiodarone lung injury: another heart failure mimic? (2002) (3)
- Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy (2005) (3)
- Potential role of antioxidants in the primary and secondary prevention of atherosclerosis in the elderly (1995) (3)
- Citizenship Status and Cardiothoracic Organ Transplantation in the United States. (2020) (3)
- Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. (2007) (3)
- Usefulness of ventilatory inefficiency in predicting prognosis across the heart failure spectrum (2021) (2)
- Left Ventricular Assist Devices for Advanced Heart Failure. (2017) (2)
- 848-5 The impact of percutaneous renal artery revascularization on QT dispersion in patients with hypertensive heart disease (2004) (2)
- The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic (2022) (2)
- Treatment of hypertension for patients with diastolic dysfunction (2003) (2)
- Nine contemporary therapeutic directions in heart failure (2019) (2)
- Left ventricular assist device use in biventricular configurations: It takes two to tango. (2018) (2)
- Abstract 3280: Heart Failure Quality of Care in the Outpatient Cardiology Practice Setting: A Report from IMPROVE HF (2007) (2)
- Do women with refractory angina respond as well as men to treatment with enhanced external counterpulsation (2002) (2)
- Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients (2021) (2)
- Highlights of the 2008 Scientific Sessions of the Heart Failure Society of America. Toronto, Ontario, Canada, September 20-23, 2008. (2009) (2)
- HDL and Heart Failure Regulation: Still Breathing but Exhausted. (2019) (2)
- Clinical relevance of circulating tnf a in decompensated advanced heart failure (1995) (2)
- Imaging markers of adverse remodeling: from organ to organelle. (2006) (2)
- Management of patients with heart failure and secondary mitral regurgitation (2020) (2)
- Abstract 2382: The Influence of Electronic Health Records on Quality of Care for Heart Failure (2008) (2)
- Resource utilization and hospital readmission associated with gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices (2018) (2)
- Non-invasive molecular screening for acute cardiac rejection: a multicenter prospective clinical study (2003) (2)
- INFLUENCE OF NICOTINE ON CIGARETTE SMOKE INDUCED RENAL DAMAGE IN ORGAN TRANSPLANTATION: AN IN VITRO STUDY WITH RENAL CELLS: 178 (2008) (2)
- Sildenafil is effective and safe in reversing pulmonary hypertension in advanced heart failure (2004) (2)
- 1051-127 Molecular pathways of cardiac allograft dysfunction independent of acute cellular rejection (2004) (2)
- 157: Early detection of cardiac allograft vasculopathy through gene expression profiling – insights of the CARGO study (2006) (2)
- Baseline Predictors of Clinical Success During Randomized Assessment of Aortic Flow Therapy in Heart Failure Exacerbation Refractory to Pharmacological Therapy: Analysis of the Multi-center MOMENTUM Trial (2008) (2)
- Magnetically Levitated Left Ventricular Assist Device. Reply. (2019) (2)
- 887-1 Combined effects of diastolic dysfunction and left ventricular (LV) remodeling on mortality in 7,267 patients with preserved LV systolic function (2004) (2)
- Organ Transplantation: Postoperative care and early complications (2011) (2)
- Development of an Outpatient Guideline for Optimal Anticoagulation Bridging in Patients With Durable Mechanical Circulatory Support (2018) (2)
- Magnetically Levitated Cardiac Pump at 2 Years. (2018) (2)
- The differential metabolic impact of tacrolimus and cyclosporine immunosuppression in black heart transplant recipients: hyperlipidemia, hypertension and hyperglycemia. (2001) (2)
- Increased prognostic value of body fat adjusted peak oxygen consumption in the evaluation of obese patients with chronic heart failure (2000) (2)
- Disease-modifying therapy and hospitalization risk in heart failure patients. (2015) (2)
- Evidence for increased cardiac and peripheral arterial vascular stiffening in heart transplantation independent of hypertension (2003) (2)
- Improvements in work efficiency result in enhanced functional status and quality of life following exercise training in heart failure (1998) (2)
- Clinical Effectiveness of CRT and ICD Therapy in Men and Women with Heart Failure: Findings from IMPROVE HF (2013) (2)
- Cardiac Xenotransplantation (2022) (2)
- On‐Line Myocardial Tissue Characterization with a New Commercially Produced Software (1996) (2)
- DIAGNOSTIC AND PROGNOSTIC UTILITY OF QUANTITATIVE CARDIAC PET EVALUATION OF CARDIAC ALLOGRAFT VASCULOPATHY (2016) (2)
- Early Use of Antiplatelet Therapy and Development of Cardiac Allograft Vasculopathy: A 5 Year Outcomes Analysis (2016) (2)
- EQUITABLE IMPROVEMENT FOR WOMEN AND MEN IN THE USE OF GUIDELINE-RECOMMENDED THERAPIES FOR HEART FAILURE: FINDINGS FROM IMPROVE HF (2010) (2)
- Incidence and Clinical Significance of Aortic Regurgitation in HeartMate 3 Continuous Flow Left Ventricular Assist Device Recipients: An Analysis from the Momentum 3 Trial Portfolio (2021) (2)
- Cardiac CT to Diagnose Left Ventricular Assist Device Outflow Graft Twist. (2019) (2)
- Transforming the interpretation of significance in heart failure trials (2019) (2)
- Adoption of hepatitis C virus-infected donor hearts: A "middle child" no more. (2019) (2)
- Targeted in vitro and in vivo gene transfer into T Lymphocytes: potential of direct inhibition of allo-immune activation (2006) (2)
- Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure Is the Strongest Negative Prognostic Factor Post Continuous Flow Ventricular Assist Device Implantation (2017) (2)
- 842-6 Anemia is associated with reduced health status measures in patients with heart failure: Results from the STAMINA: HFP (study of anemia in a heart failure population) registry (2004) (2)
- Hemodynamic Aberrancies in Left Ventricular Assist Device Associated Heart Failure Syndromes. (2022) (2)
- Lack of additional prognostic value of various diastolic parameters in patients with congestive heart failure (1999) (2)
- Microbiota and Allogeneic Hematopoietic-Cell Transplantation. (2020) (2)
- Incidence and clinical correlates of de‐novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis (2022) (2)
- Modulation of tumor necrosis factor α in advanced heart failure with cachexia is associated with anabolic effects (1996) (2)
- Postoperative bridging anticoagulation and left ventricular assist system thrombosis (2018) (2)
- Documentation of QRS Duration and NYHA Class in HF Patients after a Performance Improvement Initiative: IMPROVE HF (2010) (2)
- A specialist-nurse intervention reduced readmissions in patients hospitalized with chronic heart failure. (2002) (2)
- Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer. (2023) (1)
- The Normal and Abnormal Right Heart: Introduction to a Clinical Classification (2014) (1)
- Infection-Related Morbidity with Continuous-Flow Left Ventricular Assist Systems: A Comprehensive Analysis of the Randomized MOMENTUM 3 Trial. (2020) (1)
- 131: Gene expression and prediction of early cardiac allograft rejection: Discovery of a gene-based corticosteroid efficacy measure (2007) (1)
- Is There an Obesity Paradox in Cardiogenic Shock? (2022) (1)
- Various Techniques for Frequency Offset Estimation in OFDM System : A Survey (2015) (1)
- Difficult cases in heart failure: A hunt for reversibility: necessary and fruitful endeavor. (2000) (1)
- 784-5 Gene Transfer in a Rabbit Model of Allograft Vasculopathy (1995) (1)
- The Impact of Age, Sex, Therapeutic Intent and Severity of Advanced Heart Failure on Outcomes in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3 (Momentum 3) Pivotal Trial (2017) (1)
- ELDERLY PATIENTS ARE LESS LIKELY TO RECEIVE EVIDENCE-BASED MEDICATIONS INDICATED FOR SYSTOLIC HEART FAILURE: RESULTS FROM THE STUDY OF ANEMIA IN A HEART FAILURE POPULATION (STAMINA-HFP) REGISTRY (2010) (1)
- Heart failure with preserved ejection fraction: a bouillabaisse. (2014) (1)
- Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology (2023) (1)
- The unique management of refractory advanced systolic heart failure. (1997) (1)
- Ventricular assist devices: Destination therapy or just another stop on the road? (2004) (1)
- Burden of nursing activities during hemodynamic monitoring of heart failure patients (2018) (1)
- From crisis intervention to preventive intervention. A new approach to the management of heart failure. (1998) (1)
- Imaging the Crevasse of Left Ventricular Assist Device Infection. (2020) (1)
- Temporal alteration in B-type natriuretic peptide expression predicts allograft failure in heart transplantation (2003) (1)
- Global challenges in left ventricular assist device therapy: a tale across two continents (2022) (1)
- Controlled- and extended-release metoprolol reduced death, hospital admissions, and symptoms in chronic heart failure (2000) (1)
- Valvular heart disease (2001) (1)
- Maximal oxygen-pulse predicts clinical prognosis in patients with chronic systolic heart failure (2002) (1)
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. (2020) (1)
- Bariatric surgery and heart transplantation outcomes: A note of caution. (2020) (1)
- A Comprehensive Review (2017) (1)
- Minimal AnticoaGulation EvaluatioN To aUgment heMocompatibility - The MAGENTUM 1 Study (2018) (1)
- Heart failure with preserved systolic function in African Americans: the role of diabetes mellitus and obesity (2000) (1)
- Difficult cases in heart failure: chemotherapy-related cardiomyopathy--all that glitters is not gold. (2003) (1)
- Does hyperuricemia predict adverse clinical outcome while awaiting heart transplantation? (2001) (1)
- Evidence of ventricular/vascular uncoupling in solid organ transplant recipients with hypertension (1997) (1)
- Treatment of pulmonary hypertension: A promising new age (2002) (1)
- QuaLVAD Instrument: A New Measure of Quality of Life in Patients with a Left Ventricular Assist Device (LVAD) (2019) (1)
- Calcineurin-inhibitor withdrawal in heart transplantation recipients (the case against). (2002) (1)
- Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study. (2020) (1)
- The Scientific Impact of the Annual Meeting of the International Society for Heart & Lung Transplantation (2014) (1)
- A case report of three heart transplant patients with nocardia (2002) (1)
- Ventilation carbon dioxide production ratio in early exercise predicts poor functional: capacity and prognosis in congestive heart failure (1995) (1)
- Are beta blockers effective in African Americans with systolic heart failure? (2001) (1)
- INCIDENTAL CORONARY ARTERY CALCIFICATION ON COMPUTERIZED TOMOGRAPHY IN PATIENTS WITH EARLY STAGE NON-SMALL CELL LUNG CANCER AND OPPORTUNITIES FOR CARDIOVASCULAR RISK OPTIMIZATION (2018) (1)
- Response by Mehra and Colombo to Letter Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump". (2019) (1)
- Review: clinical gestalt strategies and clinical prediction rules have similar discriminate pretest probabilities of pulmonary embolism (2004) (1)
- 461: Intragraft Authentication of Peripheral Transcriptomic Molecular Biomarkers for Cardiac Allograft Rejection (2009) (1)
- Can maximal oxygen-consumption predict outcome of heart-failure in women as well as in men: evidence for a gender mismatch (1995) (1)
- Forward "MOMENTUM" in left ventricular assist systems: advanced engineering meets biology. (2017) (1)
- A multicenter evaluation of external outflow graft obstruction with a fully magnetically levitated left ventricular assist device. (2022) (1)
- Resource Utilization and Hospital Readmission Rates Associated with Gastrointestinal Bleeding in Patients with Continuous Flow Left Ventricular Assist Devices (2016) (1)
- Long-Term Outcomes in Heart and Lung Transplants from HCV-Viremic Donors to Uninfected Recipients: The Donate HCV Trial (2021) (1)
- Influence of Race on Improvements in Use of Guideline Recommended Heart Failure Therapies: Findings from IMPROVE HF (2010) (1)
- A Trial of Complete Withdrawal of Anticoagulation Therapy in the Heartmate 3 Pump (2019) (1)
- Abstract 3337: The Role of IL1R2 and FLT3 Gene Expression in Cardiac Allograft Rejection: A Precise Measure of Corticosteroid Effect? (2006) (1)
- Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support. (2020) (1)
- Transcatheter mitral valve intervention in advanced heart failure. (2020) (1)
- Clinical Outcomes by Intended Goal of Therapy in the MOMENTUM 3 Clinical Trial: Final Analysis of the 1028 Patient Full Cohort (2019) (1)
- Does exogenous melatonin influence sympathetic hyperactivity in heart failure? A placebo controlled clinical trial (1998) (1)
- B-Type Natriuretic Peptide Profiles in the Setting of Chronic Left Ventricular Assist Device Support (2014) (1)
- A specialist nurse intervention reduced readmissions in patients admitted to hospital with chronic heart failure (2002) (1)
- Fish oils improve body composition in cardiac cachexia by their anti-inflammatory effects (2005) (1)
- Efficacy and Safety of LCP-Tacrolimus (Envarsus XR®) Conversion Therapy in Heart Transplantation. (2020) (1)
- Alteration in b-type natriuretic peptide levels with epoprostenol therapy in pulmonary hypertension: an important marker of clinical outcome (2004) (1)
- Renin-angiotensin-aldosterone-system directed antihypertensive therapy achieves lower B-type natriuretic peptide levels compared with calcium channel blockade in heart transplantation (2002) (1)
- Secular changes in organ donor profiles and impact on heart and lung transplantation. (2020) (1)
- Adults with congenital heart disease: growing pains. (2014) (1)
- Quality of death after left ventricular assist device implantation: More questions than answers. (2019) (1)
- The Impact of Laser Transmyocardial Revascularization on Indices of Ventricular Repolarization (1998) (1)
- 46: Interventricular Dyssynchrony in Pulmonary Arterial Hypertension: Evidence for Early Right Ventricular and Septal Mechanical Activation (2008) (1)
- THE EPIDEMIOLOGY AND ECONOMIC BURDEN OF ADVANCED STAGE HEART FAILURE IN U.S. MEDICARE BENEFICIARIES (2016) (1)
- Bridging the palliative care chasm in advanced heart failure. (2021) (1)
- Risk Factors for Bleeding and Thrombosis Events on Veno-Arterial Extracorporeal Life Support: An ELSO Analysis (2019) (1)
- Exercise training as treatment of depression in heart failure. (2012) (1)
- A principal components analysis of factors associated with successful implementation of an LVAD decision support tool (2020) (1)
- Reversibility of anorexigenic valvulopathy: Reply (2001) (1)
- B-type natriuretic peptide and peak aerobic capacity: insights into allograft determinants of exercise limitations following heart transplantation (2002) (1)
- LONG-TERM OUTCOME OF TRANSMYOCARDIAL LASER REVASCULARIZATION IN CARDIAC ALLOGRAFT VASCULOPATHY: EARLY REWARDS, LATE LOSSES (1999) (1)
- The history of acute heart failure management: how far have we come? (2005) (1)
- Clinical Allograft Rejection Syndromes in Heart Transplantation (2014) (0)
- Current Status of Heart Transplantation (2014) (0)
- DEVELOPMENT OF A NONINVASIVE MOLECULAR DIAGNOSTIC ASSAY FOR ALLOGRAFT MONITORING: AUTHENTICATION WITH AN EXPERIMENTAL MODEL OF CARDIAC TRANSPLANTATION: 42 (2008) (0)
- Chapter 61 – Management of End-Stage Heart Failure (2011) (0)
- PREDICTING SURVIVAL IN URGENT (STATUS I) HEART TRANSPLANTATION: A CLINICAL PROGNOSTIC MODEL (1999) (0)
- P tility of Impedance Cardiography or the Identification of Short-Term isk of Clinical Decompensation in table Patients With Chronic Heart Failure (2006) (0)
- The historical odyssey of cardiac transplantation. (2003) (0)
- Artificial intelligence in cardiovascular disease: Challenges and benefits in developing nations. (2022) (0)
- DISTINCT MOLECULAR PATHWAYS ARE ASSOCIATED WITH DIFFERENCES IN EFFICACY OF TACROLIMUS AND CYCLOSPORINE IN HEART TRANSPLANTATION (2004) (0)
- The emergence of a dynamic intervention paradigm in heart failure. (1999) (0)
- Impact of adequacy of transplant specific education on clinical outcomes after heart transplantation (2004) (0)
- Review Article Surgery for Severe Mitral Regurgitation and Left Ventricular Failure: What Do We Really Know? (2008) (0)
- Hyperhomocysteinemia is associated with increased mean platelet volume: insights into platelet interactions in heart transplantation (2002) (0)
- The Diagnosis of Cardiomyopathy: The Cost of Lost Opportunity (2014) (0)
- THE IMMUNOMODULATORY IMPACT OF THEOPHYLLINE ON CARDIAC ALLOGRAFT REJECTION (1999) (0)
- Reply (2013) (0)
- Review: ACE inhibitors reduce mortality and hospitalization in congestive heart failure (1995) (0)
- 1126-118 Limitations of exercise cardiopulmonary testing to predict heart failure prognosis in the beta blocker era (2004) (0)
- ETHNIC DISPARITIES IN THE PHARMACOLOGICAL CHARACTERISTICS OF TACROLIMUS IN PRIMARY HEART TRANSPLANTATION.: Abstract# 696 (2000) (0)
- The incremental prognostic significance of hyperuricemia in African Americans with severe heart failure (2002) (0)
- olecular Testing in the Management of Cardiac Transplant ecipients : Initial Clinical Experience (2006) (0)
- Pharmacokinetics and pharmacodynamics of rivaroxaban in patients with heart failure (2010) (0)
- The importance of geometric configuration in predicting ventricular arrhythmias in left ventricular dysfunction (2004) (0)
- The impact of ethnicity on indices of pro-inflammatory cytokine production in chronic heart failure (2003) (0)
- STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION (2021) (0)
- Diverse populations, new techniques: non-surgical advances in heart failure 2003. (2003) (0)
- Comparable "lean" peak oxygen consumption in women and men with systolic heart failure (2000) (0)
- Donor Diabetes Mellitus Status and Contemporary Outcomes After Cardiac Transplantation. (2023) (0)
- Mechanical circulatory support for adults in Japan: A 10-year perspective. (2023) (0)
- Current and Future Challenges in Mechanical Circulatory Support (2022) (0)
- Blood pressure and goal titration of neurohormonal antagonists: the tortoise wins again? (2018) (0)
- Coronary perfusion pressure is a critical determinant of expression of B-type natriuretic peptide in pulmonary arterial hypertension (2005) (0)
- Extrapulmonary manifestations of COVID-19 (2020) (0)
- Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial. (2022) (0)
- Intravenous Iron Repletion in Patients With Continuous-Flow Left Ventricular Assist Devices (2022) (0)
- Analysis of Root Mean Square Error by varying Cyclic Prefix in MIMO-OFDM system using Polyphase Filter Bank (2015) (0)
- Comorbidity burden among heart failure patients in a medicaid population (2013) (0)
- Race, Temporary Mechanical Circulatory Support, and Clinical Outcomes after the 2018 US Adult Heart Allocation System Policy Change (2021) (0)
- Abstract 16430: Early Urine Sodium Response After Ambulatory Diuretic Bolus to Avoid Heart Failure Hospitalization (2014) (0)
- Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation (2016) (0)
- Influence of Advance Practice Nurse and Dedicated Heart Failure Clinics on Delivery of Recommended Therapies in Outpatient Cardiology Practices: IMPROVE HF Findings (2008) (0)
- Current and Future Strategies for Overcoming Diuretic Resistance in Acute Heart Failure (2020) (0)
- The Impact of Left Ventricular Assist Device Infections on Clinical Outcomes (2022) (0)
- Redefining Left Ventricular Assist Device Indications and Strategies-Reply. (2020) (0)
- ACCELERATED CARDIAC ALLOGRAFT REJECTION AND GRAFT LOSS AMONG CIGARETTE SMOKERS, ROLE OF INFLAMMATION, OXIDATIVE STRESS AND TISSUE REPAIR MOLECULES: 1579 (2008) (0)
- Does Thermal Therapy Benefit Patients With Chronic Heart Failure?–Reply–I (2010) (0)
- 901-25 The Paradox of Donor Stimulation of Endothelial-induced Smooth Muscle Growth (1995) (0)
- Clinical Decompensation in Stable Patients With Chronic Heart Failure Utility of Impedance Cardiography for the Identification of Short-Term Risk of (2006) (0)
- RACIAL DIFFERENCES IN CLINICAL OUTCOME USING TACROLIMUS AND MYCOPHENOLATE MOFETIL IMMUNOSUPPRESSION IN HEART TRANSPLANTATION.: Abstract# 693 (2000) (0)
- IS TACROLIMUS A BETTER IMMUNOSUPPRESSANT IN AFRICAN AMERICANS THAN NEORAL‐CYCLOSPORINE IN HEART TRANSPLANTATION? FIRST YEAR RESULTS OF A RANDOMIZED CLINICAL TRIAL.: Abstract# 697 (2000) (0)
- 94. Infectious Complications of Left Ventricular Assist Devices (2021) (0)
- DOSE REDUCTION OF NEUROHORMONAL ANTAGONISTS DURING HEART FAILURE HOSPITALIZATION MARKS PATIENTS AS HIGH RISK FOR READMISSION AT BOTH TERTIARY AND COMMUNITY HOSPITALS (2015) (0)
- Racial variation in heart failure comorbidities and therapy use in a medicaid population (2013) (0)
- Is heart failure more prevalent in patients with peripheral arterial disease? a systematic meta-analysis (2004) (0)
- Controlled and extended release metoprolol reduced death, hospital admissions, and symptoms in chronic heart failure (2000) (0)
- Impact of Advanced Heart Failure on Hospital Readmissions in the Elderly (2016) (0)
- 171: Does induction therapy influence the utility of gene expression testing for cardiac allograft rejection? (2007) (0)
- Physiology and hemodynamic assessment of the failing heart: Current knowledge and unmet needs for advanced heart failure (2016) (0)
- Usage of orlistat in obese patients with systolic heart failure: efficacy and tolerability (2003) (0)
- Predictive Prognostic Value of Ventilatory Inefficiency across the Spectrum of Heart Failure (2019) (0)
- BNP Levels in Outpatients with Heart Failure: Frequency of Assessment, Relationship to Symptoms, Disease Severity, and HF Quality of Care Measures (2009) (0)
- 1 Ventricular assist devices: developments in asia and global outlook for the next 10 years (2019) (0)
- In reply-The Mona Lisa Decrypted: Another Premise. (2019) (0)
- Abstract 19573: Factors Associated With Improvement in Ejection Fraction in Heart Failure Patients Following Implementation of a Practice-Based Performance Intervention: Findings From IMPROVE HF (2010) (0)
- 733-3 Successful Transplantation of Myoblasts into Adult Porcine Myocardium: A Potential Method to Repair a Failing Heart (1995) (0)
- The hi-tech age of heart failure management. (2015) (0)
- Frequency and outcome of de novo hepatitis C infection in heart transplant recipients Relationship to donor genotype, donor HCV RNA level, and immunosuppression post-transplant (2001) (0)
- 328: Sirolimus Associated Nephropathy in Cardiac Transplantation: Histological and Molecular Pathways (2009) (0)
- Revascularization in severe ventricular dysfunction: a comparison of bypass surgery and percutaneous intervention (2002) (0)
- The 500th Heart Transplant (2000) (0)
- THE QUANTITATIVE IMPACT OF FLOW CYTOMETRIC CROSSMATCH ON INDICES OF CARDIAC ALLOGRAFT REJECTION (1999) (0)
- P-144: Clinical factors associated with complete restoration of left ventricular systolic function in chronic heart failure patients treated with beta-blockers (2003) (0)
- A world view of heart failure requiring hospitalization. Foreword. (2013) (0)
- Pharmacotherapy for heart failure: the more we get to know, the more we need to know. Foreword. (2014) (0)
- Medical decisions in organ donors and heart transplant candidates with history of COVID‐19 infection: An international practice survey (2022) (0)
- Immunosuppressive therapy in the elderly heart transplant recipient (1996) (0)
- Effects of Rivaroxaban on Thrombotic Events in Heart Failure Patients With Coronary Disease and Sinus Rhythm (2018) (0)
- Serial Evaluation of Von Willebrand Factor Performance with a Fully Magnetically Levitated Centrifugal Continuous Flow Left Ventricular Assist Device (2016) (0)
- A Multi-Center Evaluation of Outflow Graft Obstruction with a Fully Magnetically Levitated Left Ventricular Assist Device (2022) (0)
- Optimizing heart transplant patient education: is once enough? (2001) (0)
- 377: An innovative chimeric gene construct targeting p21 gene transfer into T lymphocytes (2007) (0)
- Death messengers (2007) (0)
- Abstract 3003: Greater Improvement in Heart Failure Care Quality With a Performance Improvement Initiative is Largely Independent of Patient and Practice Characteristics (2009) (0)
- The interaction of underlying etiology of pulmonary hypertension and response to bosentan (2004) (0)
- Chronotropic reserve beyond anerobic threshold (CRAT) predicts survival in advanced heart failure (2003) (0)
- Modulation of B-Type Natriuretic Peptide with Epoprostenol in Pulmonary Arterial Hypertension (2004) (0)
- Variability Across Implanting Centers in Short and Long-Term Mortality and Adverse Events in Patients on HeartMate 3 Support: A Momentum 3 Secondary Analysis (2022) (0)
- MEDICATION DOSING ADHERENCE IN OUTPATIENTS WITH HEART FAILURE FOLLOWING IMPLEMENTATION OF A PRACTICE-BASED PERFORMANCE IMPROVEMENT INTERVENTION: RESULTS FROM IMPROVE HF (2010) (0)
- JHLT highlights 2011: cardiothoracic transplantation, pulmonary hypertension, and mechanical circulatory support. (2012) (0)
- MY APPROACH to left ventricular assist device therapy. (2015) (0)
- The Impact of Aspirin Dose on Hemocompatibility-Related Adverse Events during HeartMate 3 Support - An Analysis from the MOMENTUM 3 Trial. (2020) (0)
- Influence of Atrial Fibrillation on the Use of CRT and ICD Therapy in Heart Failure: Findings from IMPROVE HF (2009) (0)
- Heart Failure (2020) (0)
- 682 Antibody Mediated Rejection in Heart Transplant Biopsies (2011) (0)
- Obesity and advanced heart failure: the differential impact of body weight on b-type natriuretic peptide and proinflammatory cytokine expression (2003) (0)
- Educational affairs at the International Society for Heart and Lung Transplantation: Perspective and governance of post-graduate learning dimensions. (2014) (0)
- the Heart Rhythm Society Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Patient Selection for Cardiac Resynchronization Therapy : From the Council on Clinical (2012) (0)
- Ventricular asynchrony after heart transplantation: prevalence and clinical correlates. (2001) (0)
- Hypokalemia in heart failure: A low or a high point? (2020) (0)
- Are Patient Age and Gender Associated with Delivery of Recommended HF Therapies (2007) (0)
- Efficacy and Safety of an Intravenous Loop Diuretic Dosing Protocol for Ambulatory Management of Worsening Heart Failure (2018) (0)
- PROGNOSTIC IMPORTANCE OF POOR CARDIORESPIRATORY FITNESS IN PATIENTS WITH CANCER REFERRED FOR EXERCISE TREADMILL TESTING (2018) (0)
- Fungal infections in orthotopic heart transplant recipients: A 10-year retrospective study at Ochsner Medical Institutions (2001) (0)
- Lower hemoglobin is associated with reduced survival in unselected patients with heart failure: results from the study of anemia in a heart failure population (STAMINA-HFP) registry (2004) (0)
- Dyssynchrony Should Not Receive Cardiac Resynchronization Therapy All Patients With Heart Failure and Intraventricular Conduction Defect or (2011) (0)
- SHORT TERM USE OF INDUCTION OKT3 IN URGENT HEART TRANSPLANTATION: IMPACT ON LONG TERM CLINICAL OUTCOMES (1998) (0)
- Obesity influences the accuracy of B-type natriuretic peptide measurement in chronic heart failure (2003) (0)
- Denton A . Cooley ' s 50 th Anniversary in Medicine (0)
- 1145-125 The role of sildenafil in establishing pulmonary arterial reactivity in advanced heart failure (2004) (0)
- SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE—RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1 (2001) (0)
- 1146-111 Exercise cardiopulmonary predictors of major clinical events in advanced heart failure (2004) (0)
- More Than a Hemodynamic Marker Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart (2006) (0)
- Comprar Advances in Heart Transplantation, An Issue of Heart Failure Clinics,3-1 | M. Mehra | 9781416043201 | Saunders (2007) (0)
- Improved Medical Resource Use by Deploying a Novel Multidisciplinary Team-Based In-Hospital MCS Unit (2016) (0)
- Intravenous Iron or Red Blood Cell Supplementation and Risk of Serious Infection in Left Ventricular Assist Device Patients (2020) (0)
- Low-intensity anti-coagulation using Vitamin K antagonists and Factor X activity: A validation analysis of the MAGENTUM-1 study. (2019) (0)
- Additional prognostic value of body fat adjusted peak oxygen consumption in ambulatory patients with heart failure (1999) (0)
- Insights from High-Performing Heart Transplant Centers across the Recipient Risk-Spectrum (2019) (0)
- In reply-Mona Lisa and Postpartum Hypothyroidism. (2019) (0)
- Implementation of Patient-Centered Shared Decision Making for LVAD Candidates: Year 1 Results of a Multi-Site Study. (2020) (0)
- Prevalence and Characteristics of Prolonged QRS Duration in Outpatients with Left Ventricular Systolic Dysfunction: An IMPROVE HF Analysis (2009) (0)
- Neonatal congenital heart disease and "complex" heart failure. (2002) (0)
- Device Therapy for Heart Failure Patients (2011) (0)
- “Quilty” Biopsies Are Independently Associated with Improved Post Transplant Survival (2010) (0)
- Importance of left atrial volume in predicting reduced peak aerobic capacity in advanced systolic dysfunction (2005) (0)
- Stroke Patterns and Implications for Ventricular Functional Remodeling in Left Ventricular Assist Systems (2018) (0)
- RELATIONSHIP BETWEEN CARDIOLOGY PRACTICE TEACHING STATUS AND IMPROVEMENT IN THE USE OF EVIDENCE-BASED THERAPY FOR HEART FAILURE: FINDINGS FROM IMPROVE HF (2010) (0)
- Untimely Trial Publication: A Sin of Omission? (2020) (0)
- Practice Guidelines in Cardiovascular Disease: How Defining the Evidence Can Impact the Guidelines (2015) (0)
- Clinico-pathological mismatch of etiological classification in heart failure: Preponderance and clinical implications (2004) (0)
- Mechanical circulatory support: Patient selection, optimization, and in-patient management of the patient with a left ventricular assist device (2016) (0)
- Abstract 2991: Effect of Rivaroxaban on Biomarkers of Hypercoagulability in Patients With Chronic Heart Failure (2009) (0)
- Blood Pressure Profiles of Patients with Left Ventricular Assist Devices (2014) (0)
- Hypokalemia in heart failure: A low or a high point? (2020) (0)
- CHF: "compressive" heart failure? A clinical review of metastatic cardiac tumors. (2004) (0)
- Pulmonary Arterial Hypertension: The Role of Right Ventricular Failure--Diagnosis and Therapy (2020) (0)
- A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study (2018) (0)
- Outcomes in Smaller Body Size Adults after HeartMate 3 Left Ventricular Assist Device Implantation. (2022) (0)
- 78: Patterns and clinical correlates of intramyocardial and epicardial fat deposition in advanced heart failure (2006) (0)
- Poor quality of life in chronic heart failure is independently predictive of worse short-term outcome (2004) (0)
- Abstract 3315: Antioxidant N-acetyl Cysteine Extinguish Cigarette Smoke Induced Myocardial Infarction by Inhibiting Inflammation and Oxidative Stress in a Rat Model (2009) (0)
- Comparison of Medical Treatment in Outpatients Receiving Device Therapy for Systolic Dysfunction: A Report from IMPROVE HF (2008) (0)
- Cocaine Use in Organ Donors and Long-Term Outcome after Heart Transplantation: An ISHLT Registry Analysis. (2020) (0)
- Tissue characterization by integrated backscatter using new commercially produced software in transplanted and cardiomyopathic hearts (1995) (0)
- Abdominal pain in a patient who had had cancer. (1992) (0)
- Abstract 15503: Reasons for Incomplete Decongestion at Heart Failure Discharge from a Tertiary Center and Community Hospital (2014) (0)
- D i f f i c u l t ca s e s i n He a r t fa i l u r e (2007) (0)
- Long-Term Burden of Hemocompatibility Related Adverse Events in the MOMENTUM 3 Trial: Final Analysis of the 1028 Patient Cohort (2019) (0)
- Sildenafil is effective in the evaluation of severe pulmonary hypertension in advanced heart failure (2003) (0)
- 464: Oxidative Stress Induced by TGF-beta Uniformly Influences the Development of Chronic Allograft Nephropathy in Organ Transplantation (2008) (0)
- From Crisis Intervention (0)
- RECONSTRUCTING THE CREB-NETWORK FROM 285 LEUKOCYTE-ARRAYS in CARGO YIELDS INSIGHT INTO TRANSCRIPTION FACTOR FUNCTION DURING QUIESCENCE AND REJECTION. (2006) (0)
- 140 - Orthopnea is Frequently Under-Reported in Routine Visits Despite its Impact on Quality of Life (2017) (0)
- Data from Mehra et al. (2020-05-29), "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" (2020) (0)
- SEX-SPECIFIC EFFECTS OF HEMODYNAMIC-GUIDED MANAGEMENT ON HEART FAILURE OUTCOMES: A POOLED ANALYSIS FROM THE CHAMPION AND GUIDE-HF TRIALS (2023) (0)
- Get a move on heart failure. (2015) (0)
- dioxide production ratio in early exercise predicts poor functional capacity in congestive heart failure (1996) (0)
- Devices in heart failure: new approaches (2005) (0)
- CostAnalysis andClinical Outcomes (2015) (0)
- Early Assessment and Treatment Acute Heart Failure Syndromes in Patients With Coronary Artery Disease (2009) (0)
- 87. Heart and Lung Transplants From HCV-Viremic Donors to Uninfected Patients: Longer-Term Follow-Up (2019) (0)
- Cyclin Kinase Inhibitor p21-Mediated Immune-Tolerance (2007) (0)
- IN-HOSPITAL RESOURCE UTILIZATION ASSOCIATED WITH GASTROINTESTINAL BLEEDING IN PATIENTS WITH CONTINUOUS FLOW-LEFT VENTRICULAR ASSIST DEVICES (2016) (0)
- 133: Stromal Cell-Derived Factor-1(SDF-1): A Novel Cardiac Rejection Biomarker (2009) (0)
- Infectious complications in heart transplantation are influenced by ethnic disparities in immunoglobulin expression (2003) (0)
- 229: Clinical Benefits of Pharmacological Therapy in Exercise Induced Pulmonary Arterial Hypertension (2009) (0)
- Lean tissue adjusted peak oxygen consumption in congestive heart failure (2001) (0)
- P-177: Renal angiography during surveillance coronary angiography in post-cardiac transplant patients is not indicated (2001) (0)
- Emergency cardiovascular care: from ED to CCU and beyond. (2012) (0)
- CYCLIN KINASE INHIBITOR P21-MEDIATED IMMUNE TOLERANCE: DIRECT AND INDIRECT EVIDENCE: 550 (2008) (0)
- (149) - Hemocompatibility Related Outcomes in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3 (Momentum 3) Pivotal Trial (2017) (0)
- Does epicardial coronary disease predict tissue myocardial perfusion in heart transplantation? Microcirculatory insights (2002) (0)
- Abstract 2416: Progressive Improvement in Cardiac Performance produced by Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results from the MOMENTUM Trial (2008) (0)
- Response by Netuka et al regarding the article "Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study". (2018) (0)
- The differential impact of spironolactone on patterns of pro-inflammatory cytokine expression in advanced heart failure (2003) (0)
- Financial Implications of Ambulatory Diuretic Therapy Instead of Hospitalization for the Treatment of Decompensated Heart Failure (2016) (0)
- A Comparative Analysis of Long-Term Outcomes in the MOMENTUM 3 Pivotal Trial and Continued Access Protocol Post-Approval Study Phase: A Study of over 1500 HeartMate 3 Implants (2021) (0)
- Does Low-Intensity Anticoagulation Using Vitamin K Antagonists Correlate with Factor X Activity Inpatients Implanted with the HeartMate 3 Pump? A Validation Analysis of the MAGENTUM 1 Study (2019) (0)
- Highlights of the 2007 Scientific Meeting of the Heart Failure Society of America (2008) (0)
- Cardiac power output is a primary determinant of B-type natriuretic peptide expression in severe heart failure (2005) (0)
- Impaired renal function is common in outpatients with heart failure: results from the STAMINA-HFP (study of anemia in a heart failure population) registry (2003) (0)
- PCV12 Impact of Comorbidities on Heart Failure Hospitalization Risk: A Contemporary Medicaid Cohort Analysis (2012) (0)
- Implementation Science and Global Connectivity: HFSA's Path Forward. (2016) (0)
- The utility of b-type natriuretic peptide levels in demarcating the distinct hemodynamic profiles of chronic heart failure (2004) (0)
- Predictors of Favorable Outcome in Patients Bridged to Transplant with Temporary Mechanical Circulatory Support Devices (2019) (0)
- tility of Impedance Cardiography or the Identification of Short-Term isk of Clinical Decompensation in table Patients With Chronic Heart Failure (2006) (0)
- DEVELOPMENT OF CYCLIN KINASE INHIBITOR AS A POTENT IMMUNOSUPPRESSIVE DRUG: 2703 (2008) (0)
- The Panvascular Interplay in Pathophysiology and Prognosis of Cardiac Allograft Vasculopathy. (2022) (0)
- ARE BIOCHEMICAL INDICES OF ACUTE CARDIAC INJURY USEFUL IN PREDICTING CARDIAC ALLOGRAFT REJECTION (1998) (0)
- HFSA 2006 Comprehensive Heart Failure Practice Guideline HFSA 2006 Comprehensive Heart Failure Practice Guideline (2006) (0)
- Advances in Heart Transplantation, An Issue of Heart Failure Clinics,3-1 (2007) (0)
- P-466: A comparision of dobutamine stress echocardiography and adenosine Tc-99m Sestamibi in pre-operative cardiac evaluation for abdominal transplant candidates (2005) (0)
- Abstract P301: Are Variations in Delivery of Guideline Recommended Therapies by Cardiology Practices Reduced After Implementation of a Performance Improvement Initiative? Findings From IMPROVE HF (2011) (0)
- Future directions in advanced heart failure (2016) (0)
- Donor-recipient size match in thoracic transplantation: back to fundamentals. (2019) (0)
- Variation in HF Quality of Care among US Outpatient Practices: Analysis of 131 Cardiology Practices in IMPROVE HF (2007) (0)
- Comprar Clinical Challenges In Heart Failure | M. Mehra | 9781846920448 | Clinical Pub. (2011) (0)
- P-381: Efficacy of B-type natriuretic peptide in assessment of heart failure severity in African American heart failure patients (2002) (0)
- The 500 heart transplant. (2000) (0)
- Doppler tissue imaging identifies altered activation sequences in stable heart transplant recipients (2004) (0)
- Heart Failure (2020) (0)
- Diastolic heart failure and B-type natriuretic peptide: The important influence of female gender and underlying coronary artery disease (2003) (0)
- The ISHLT Registries in the Era of Big Data with Global Reach (2015) (0)
- FACTORS ASSOCIATED WITH IMPROVEMENT IN GUIDELINE-BASED USE OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ELIGIBLE HEART FAILURE PATIENTS BY IMPLEMENTING A PRACTICE-BASED PERFORMANCE IMPROVEMENT INTERVENTION: RESULTS FROM IMPROVE HF (2011) (0)
- BODY COMPOSITION AND SURVIVAL IN PATIENTS WITH SYSTOLIC HEART FAILURE AND UNDERLYING CORONARY HEART DISEASE (2014) (0)
- Budget impacts of potential modification of risk factors for heart failure hospitalizations: a contemporary medicaid cohort analysis (2013) (0)
- 327: Differential Effects of Cyclosporine, Sirolimus and Tacrolimus on Intragraft mRNA Expression of Pro-Inflammatory and Cytotoxic Molecular Pathways (2009) (0)
- The effect of obesity on cardiopulmonary parameters in the prognostic evaluation of congestive heart failure (1999) (0)
- LEUKOCYTE-ARRAYS in CARGO YIELDS INSIGHT INTO TRANSCRIPTION FACTOR FUNCTION DURING QUIESCENCE (2006) (0)
- The predictive impact of abnormalities in ventricular repolarization on noncellular allograft rejection with hemodynamic compromise (1998) (0)
- Large Variation in Heart Transplant Selection Practices During the COVID-19 Pandemic (2022) (0)
- Highlights of the Annual Scientific Meeting of the Heart Failure Society of America 2016. (2016) (0)
- P-357: Incidental renal artery stenosis in heart transplantation: Prevalence and clinical implications (2005) (0)
- Confluence of the Physical Brain and Perceptual Mind With Ventricular Assist Devices. (2021) (0)
- 351: Immune Activation and Cardiac Allograft Survival: Effects of Donor and Recipient Tobacco Smoke Exposure (2009) (0)
- Outpatient Documentation of NYHA Functional Class and/or Activity Level in HF Patients: A Report from IMPROVE HF (2007) (0)
- Reply to Geisen et al, Acquired Von Willebrand Syndrome and Left Ventricular Assist Devices. (2019) (0)
- Exercise Training eduction in C-Reactive Protein Through ardiac Rehabilitation and Exercise Training (2016) (0)
- The Diagnostic and Prognostic Utility of Circulating Serum Myeloperoxidase Levels in Patients Presenting with Dyspnea (2008) (0)
- The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients (2022) (0)
- capacity in congestive heart failure . in early exercise predicts poor functional Ventilation / carbon dioxide production ratio (0)
- Should all patients with heart failure and intraventricular conduction defect or dyssynchrony receive cardiac resynchronization therapy? All Patients With Heart Failure and Intraventricular Conduction Defect or Dyssynchrony Should Not Receive Cardiac Resynchronization Therapy C ONTROVERSIES IN C ARD (2006) (0)
- INCREMENTAL PROGNOSTIC VALUE OF CORONARY FLOW RESERVE IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (2013) (0)
- Sildenafil and b-type natriuretic peptide modulation in chronic heart failure complicated by pulmonary hypertension (2004) (0)
- Concomitant Valvular Procedures During LVAD Implantation and Outcomes: An Analysis of the MOMENTUM 3 Trial Portfolio (2022) (0)
- Home intravenous inotropic therapy in advanced heart failure: Cost analysis and clinical outcomes (1996) (0)
- Response by Mehra et al to Letter Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure". (2017) (0)
- Beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival: Reply (2003) (0)
- Heart Failure (2018) (0)
- Abstract 13445: Patterns and Outcomes of Thoracic Organ Transplantation Across Citizenship Status in the United Status (2020) (0)
- Foreword. The Winning Team in Heart Failure: Dimensionality of Care Redesign. (2015) (0)
- The relationship between epicardial coronary disease, tissue myocardial perfusion and survival in heart transplantation (2004) (0)
- Immune Checkpoint Inhibitors in Thoracic Transplant Recipients: A Registry Initiative. (2020) (0)
- “HEARTPAL”: SPECIALTY-ALIGNED, LONGITUDINAL PALLIATIVE CARE IN PATIENTS WITH ADVANCED HEART FAILURE (2023) (0)
- Left Ventricular Dimension Decrement Index Early After LVAD Implantation: A Novel Risk Marker for Late Pump Thrombosis (2015) (0)
- Cardiac allograft vasculopathy in the elderly heart transplant recipient (1996) (0)
- Machine learning, artificial intelligence and mechanical circulatory support: A primer for clinicians. (2021) (0)
- Mechanical circulatory support: Outpatient management (2016) (0)
- (662) - Does Angiotensin Pathway Inhibition Influence Non-Surgical Bleeding in Durable Mechanical Circulatory Support? (2017) (0)
- Advanced heart failure in perspective (2016) (0)
- Is recrudescent tobacco exposure following heart transplantation associated with expression of atherothrombosis risk markers (2003) (0)
- Significant Gaps in Adherence to Guideline Recommended Adjunctive Heart Failure Therapies among Outpatient Cardiology Practices: Findings from IMPROVE HF (2008) (0)
- Discrepancy between estimated mets and measured mets on exercise treadmill testing (1994) (0)
- Antibody Responses to COVID-19 Vaccination in Left Ventricular Assist Devices (2022) (0)
- Perspectives in pediatric cardiology, volume 4: Epidemiology of congenital heart disease Edited by Charlotte Ferencz Christopher A. Loffredo Judith D. Rubin Carol A. Magee Futura Publishing Company, Inc., Mount Kisco, NY (1903) 353 pages, illustrated, $75.00 ISBN: 0–87993–553–7 (1994) (0)
- Clinicians and nutraceutical use in cardiology patients: ignorance and neglect. (2010) (0)
- Rationale and Design of a Randomized Controlled Trial of Donor-Derived Cell-Free DNA to Detect Rejection in Cardiac Transplantation (DETECT) (2022) (0)
- Shared Decision Making In Cardiology Practice: 15 Month Results of A Multi-Site Study of Decision Aid Implementation (2020) (0)
- Acute Inpatient Rehabilitation Facilitates Post-Implant Recovery of High-Risk LVAS Recipients (2018) (0)
- The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems. (2020) (0)
- Usefulness of Right Heart Assessment on Ramp Echocardiography After Continuous-Flow LVAD Implantation: A Missed Opportunity? (2015) (0)
- Atrial fibrillation and heart failure: it takes two to tango. Foreword. (2013) (0)
This paper list is powered by the following services:
Other Resources About Mandeep R. Mehra
What Schools Are Affiliated With Mandeep R. Mehra?
Mandeep R. Mehra is affiliated with the following schools:
